Microenvironment-dependent intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer (original) (raw)

The role of selected molecular factors in ovarian cancer metastasis

Jakub Zurawski

Ginekologia Polska

View PDFchevron_right

My pathway to understanding the role of the tumour microenvironment in cancer progression

Carmela Ricciardelli

Endocrine-Related Cancer, 2016

View PDFchevron_right

Treatment and prognosis of epithelial ovarian cancer

ahmad reza arab ameri

2008

View PDFchevron_right

Intratumoral Heterogeneity in the Self-Renewal and Tumorigenic Differentiation of Ovarian Cancer

Maty Tzukerman

STEM CELLS, 2012

View PDFchevron_right

Behaviour and Prognosis of Ovarian Cancer With Rare Metastatic Sites

Omar Hamdy

2021

View PDFchevron_right

Characterization of ovarian cancer cell lines as in vivo models for preclinical studies

Kristen Bunch

Gynecologic Oncology, 2016

View PDFchevron_right

Analysis of Gene Expression in Early-Stage Ovarian Cancer

Giovanna Chiorino

Clinical Cancer Research, 2008

View PDFchevron_right

Therapeutical Cues from the Tumor Microenvironment

Federico Todaro

Advances in Cancer Therapy, 2011

View PDFchevron_right

Treatment-Related Protein Biomarker Expression Differs between Primary and Recurrent Ovarian Carcinomas

D. Zajchowski

Molecular Cancer Therapeutics, 2012

View PDFchevron_right

Cancer prevention and therapy through the modulation of the tumor microenvironment

Kanya Honoki

Seminars in Cancer Biology, 2015

View PDFchevron_right

Current Challenges and Future Directions in the Management of Ovarian Cancer: Proceedings of the First Global Workshop on Ovarian Cancer

Paula Fracasso

Clinical Ovarian Cancer, 2010

View PDFchevron_right

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

Maria Vieito

Molecular Cancer, 2014

View PDFchevron_right

The importance of the tumor microenvironment in the therapeutic management of cancer

Anaëlle Duray

Expert Review of Anticancer Therapy, 2015

View PDFchevron_right

Tertiary Cytoreduction for Recurrent Epithelial Ovarian Cancer: a Multicenter Study in Turkey

hasan turan

Asian Pacific Journal of Cancer Prevention, 2016

View PDFchevron_right

Integrated genomic analyses of ovarian carcinoma

William Chang

Nature, 2011

View PDFchevron_right

Epithelial Ovarian Cancer: Disease Etiology, Treatment, Detection, and Investigational Gene, Metabolite, and Protein Biomarkers

Taufika Williams

Journal of Proteome Research, 2007

View PDFchevron_right

Description of an endometrioid ovarian cancer cell line

Scott Weaver

Gynecologic Oncology, 1989

View PDFchevron_right

A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review)

Giuseppa Scandurra

International Journal of Oncology, 2021

View PDFchevron_right

Coordinately Up-Regulated Genes in Ovarian Cancer

Donald Schwartz

Cancer Research, 2001

View PDFchevron_right

Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer

Ruby Huang

Current Drug Targets, 2012

View PDFchevron_right

Role of tumor microenvironment in ovarian cancer pathobiology

Neveen Said

Oncotarget, 2018

View PDFchevron_right

Progesterone reduces cell survival in primary cultures of endometrioid ovarian cancer

Flavia Morales-Vásquez

Journal of Ovarian Research, 2019

View PDFchevron_right

The second annual conference of International ovarian cancer consortium and the symposium on tumor microenvironment and therapeutic resistance

Ciro Isidoro

Genes & Cancer, 2016

View PDFchevron_right

Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III–IV epithelial ovarian cancer

Takeshi Motohara

International Journal of Clinical Oncology, 2021

View PDFchevron_right

The use of cytogenetics in understanding ovarian cancer

Jeremy A . Squire

Biomedicine & Pharmacotherapy, 2004

View PDFchevron_right

Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer

Kevin Elias

Research Square (Research Square), 2021

View PDFchevron_right

Epithelial Ovarian CancerPractice Guidelines in Oncology

Zoe Fraser

2011

View PDFchevron_right

Specialized Pathology Review in Patients With Ovarian Cancer

Dietmar Schmidt

International Journal of Gynecological Cancer, 2013

View PDFchevron_right

Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities

Neveen Said

Cancer medicine, 2018

View PDFchevron_right

Gene Expression Profiling Reveals Novel Candidate Markers of Ovarian Carcinoma Intraperitoneal Metastasis

Radka Václavíková

Journal of Cancer, 2017

View PDFchevron_right

DNA damage repair in ovarian cancer: unlocking the heterogeneity

Kay Gee

Journal of Ovarian Research, 2018

View PDFchevron_right

First-Line and Maintenance Therapy for Ovarian Cancer: Current Status and Future Directions

Luisa Sánchez Lorenzo

Drugs, 2014

View PDFchevron_right

Chromosomes 6 and 18 induce neoplastic suppression in epithelial ovarian cancer cells

Ken Choi

2009

View PDFchevron_right

Ovarian Cancer - The Silent Killer

Debashis Dutta

Journal of Tumor Research, 2018

View PDFchevron_right

Microenvironmental Regulation of Ovarian Cancer Metastasis

Francoise Marga

Cancer Treatment and Research, 2009

View PDFchevron_right